|
AFTPH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.90170143258229E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66530139572774E-11 |
| Normal-vs-Stage2 |
1.90313999999248E-05 |
| Normal-vs-Stage3 |
3.63770000000319E-06 |
| Normal-vs-Stage4 |
1.71723999999873E-05 |
| Stage1-vs-Stage2 |
2.779600E-01 |
| Stage1-vs-Stage3 |
5.864200E-01 |
| Stage1-vs-Stage4 |
7.761000E-01 |
| Stage2-vs-Stage3 |
6.400800E-01 |
| Stage2-vs-Stage4 |
3.065600E-01 |
| Stage3-vs-Stage4 |
5.968000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.33439967145932E-11 |
| Normal-vs-AfricanAmerican |
1.47399999983477E-08 |
| Normal-vs-Asian |
3.964700E-03 |
| Caucasian-vs-AfricanAmerican |
5.717200E-01 |
| Caucasian-vs-Asian |
6.994200E-01 |
| AfricanAmerican-vs-Asian |
8.354800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34601227333542E-12 |
| Normal-vs-Female |
3.0422999997004E-07 |
| Male-vs-Female |
7.834400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.75569575439272E-11 |
| Normal-vs-Extreme_Weight |
1.62470037423645E-12 |
| Normal-vs-Obese |
1.21060000024542E-07 |
| Normal-vs-Extreme_Obese |
4.937500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.005000E-01 |
| Normal_Weight-vs-Obese |
1.133010E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.196490E-02 |
| Extreme_Weight-vs-Obese |
1.576090E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.649600E-02 |
| Obese-vs-Extreme_Obese |
1.360770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.24789999947461E-07 |
| Normal-vs-Age(41-60Yrs) |
3.72580000185252E-09 |
| Normal-vs-Age(61-80Yrs) |
1.45309986265829E-10 |
| Normal-vs-Age(81-100Yrs) |
2.13560000017488E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.043600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.907800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.013800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.277250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.792200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.695400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71207492627445E-12 |
| Normal-VS-Type2 PRCC |
3.85099999666849E-08 |
| Normal-VS-KIRP CIMP |
1.07029999996122E-06 |
| Normal-VS-Unclassified PRCC |
1.516800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.113800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.806000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.476400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.850550E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.973000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.211570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19890000546985E-09 |
| Normal-vs-N1 |
3.7582000000036E-05 |
| Normal-vs-N2 |
3.77289999999864E-05 |
| N0-vs-N1 |
3.733800E-01 |
| N0-vs-N2 |
3.419800E-01 |
| N1-vs-N2 |
1.206300E-02 |
|
|
